PPT Slide

• Oral insulin was safe and well-tolerated

  • no hypoglycemia in diet-controlled subjects
  • no SAEs
  • no weight gain

• OGTT data shows evidence of effect

  • clinically relevant decreases in fasting blood glucose, 2 hr post-load glucose, and blood glucose AUC

• Oral insulin absorption evident

  • clear peaks observed at 15-20 minutes post-dose
  • oral insulin efficacy observed in “real-life” outpatient dosing design

• Decreased fasting blood glucose

  • Significant decreases in mean FBG

Emisphere – Multi-Dose Study Conclusions

Previous slide

Next slide

Back to first slide

View graphic version